세계의 신경과 기기 시장(2024-2028년)

The neurology devices market is forecasted to grow by USD 7.22 bn during 2023-2028, accelerating at a CAGR of 8.06% during the forecast period. The report on the neurology devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, growing geriatric population, and increasing funding for neurology and related research.

Technavio's neurology devices market is segmented as below:

By End-user

• Hospitals
• ASCs
• Others

By Product

• Neurostimulation devices
• Interventional neurology devices
• Neurosurgery devices
• Cerebrospinal fluid management devices
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advances in neurology devices as one of the prime reasons driving the neurology devices market growth during the next few years. Also, increasing number of initiatives supporting research related to neurostimulation technology and growing medical tourism in emerging economies will lead to sizable demand in the market.

The report on the neurology devices market covers the following areas:

• Neurology devices market sizing
• Neurology devices market forecast
• Neurology devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices market vendors that include Abbott Laboratories, Allengers Medical Systems Ltd., Becton Dickinson and Company, Boston Scientific Corporation, Cadence Inc., Helius Medical Technologies Inc., Hospital Equipment Manufacturing Co., Integra Lifesciences Corp., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, MicroPort Scientific Corp., Natus Medical Incorporated, NeuroPace Inc., Nihon Kohden Corp., Stryker Corp., The Magstim Co. Ltd., Zimmer Biomet Holdings Inc., B.Braun SE, Penumbra Inc., and Rapid Medical Ltd.. Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global neurology devices market 2018 - 2022
• 4.2 End-user Segment Analysis 2018 - 2022
• 4.3 Product Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments
• 6.2 Comparison by End-user
• 6.3 Hospitals - Market size and forecast 2023-2028
• 6.4 ASCs - Market size and forecast 2023-2028
• 6.5 Others - Market size and forecast 2023-2028
• 6.6 Market opportunity by End-user

7 Market Segmentation by Product

• 7.1 Market segments
• 7.2 Comparison by Product
• 7.3 Neurostimulation devices - Market size and forecast 2023-2028
• 7.4 Interventional neurology devices - Market size and forecast 2023-2028
• 7.5 Neurosurgery devices - Market size and forecast 2023-2028
• 7.6 Cerebrospinal fluid management devices - Market size and forecast 2023-2028
• 7.7 Others - Market size and forecast 2023-2028
• 7.8 Market opportunity by Product

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Japan - Market size and forecast 2023-2028
• 9.11 China - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 B.Braun SE
• 12.5 Becton Dickinson and Company
• 12.6 Boston Scientific Corporation
• 12.7 Cadence Inc.
• 12.8 Integra Lifesciences Corp.
• 12.9 Johnson and Johnson Services Inc.
• 12.10 LivaNova PLC
• 12.11 Medtronic
• 12.12 MicroPort Scientific Corp.
• 12.13 Natus Medical Incorporated
• 12.14 Nihon Kohden Corp.
• 12.15 Penumbra Inc.
• 12.16 Stryker Corp.
• 12.17 Zimmer Biomet Holdings Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations